9 highly anticipated FDA decisions in second half of 2023
6 obesity treatment clinical trials to watch
Lilly to buy European ADC player Emergence Therapeutics
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
*please scroll down for all the latest news*image: 
Original Article
June 30 2023 – 9 highly anticipated FDA decisions in second half of 2023
